Pfizer is expanding its multibillion-dollar cost-cutting effort that began in 2023, announcing $1.7 billion in new planned reductions.
The new round of cuts disclosed Tuesday is part of Pfizer’s "cost realignment" program, with $1.2 billion ...
↧